drugset / Trial / NCT00246142

A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.

NCT00246142 ↗

Phase 3 Completed 76 enrolled Ipsen
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether electrical stimulation enhances the effect of botulinum toxin type A (Dysport®) on myofascial pain syndrome.

Timeline

Start
2005-04
Primary completion
2007-06-27
Completion
2007-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — Other